Plavix (clopidogrel): Drug Safety Communication - Long-term Treatment Does Not Change Risk of Death
[Posted 11/06/2015] AUDIENCE: Cardiology, Hematology, Surgery ISSUE: An FDA review has determined that long-term use of the blood-thinning drug Plavix (clopidogrel) does not increase or decrease overall risk of death in patients with, or at risk for, heart …